Patient Engagement Manager
Transcription
Patient Engagement Manager
Position Patient Engagement Manager Responsible Therapeutic Development Director (TDD) Contract duration CDI full time Salary 34 000 to 38 000 € for one full time equivalent Location EURORDIS Headquarters Paris Plateforme Maladies Rares, 96 rue Didot, Paris 14ème, France Main scope of the position: In the area of therapeutic development, EURORDIS is recognised for its credible network of more than 650 member patient groups in 61 countries and over 200 highly involved volunteers, as well as its ability to advocate at the European level on behalf of rare disease patients. EURORDIS is recognised for its major contributions toward the adoption of the EU Regulation on Orphan Medicinal Products (1999), EU Pharmaceutical Review (2003), EU Regulation for Paediatric Use of Medicines (2006), EU Regulation on Advanced Therapy Medicinal Products (2007), the Commission Communication “Rare Diseases: Europe’s challenges” (2008), the Council Recommendation for Action on Rare Diseases (2009) and the EU Directive on Patient Rights to Cross Border Health Care (2011). EURORDIS plays an active role in the EU decision making process through its implication in several Scientific Committees and Working Parties of the European Medicines Agency as well as the Commission Expert Group on Rare Diseases and on Cancer Control. EURORDIS has established a long term and fruitful dialogue with most pharmaceutical and biotech companies involved in therapy development for rare diseases. The Operations Unit is in charge of all research, registries, biobanks, therapeutic development, information and access to medicines, social services, health and social research and patient service activities of EURORDIS. As of early 2015, the Operations Team comprised twelve persons within a EURORDIS total staff of 30. The position of Patient Engagement Manager is an update/enlargement of a position created in 2008 in the context of the recruitment of a Therapeutic Development Manager. This update aims at addressing the challenges of an increasing number of orphan medicinal products and innovative therapies for rare diseases, the increasing involvement of EURORDIS in the life cycle of the product from orphan designation, clinical development, protocol assistance, premarketing access, marketing application, risk management programme, registries, public information to patients, real access for patients, as well as the increasing involvement of EURORDIS in the new opportunities for patient engagement, parallel scientific advice/ Health Technology Assessment (HTA), early dialogues, public/private partnerships… For these reasons this position will not be dedicated to Therapeutic Development only but to all aspects of Rare Disease Therapies, including information and access. The Patient Engagement Manager is supervised by the Therapeutic Development Director and will liaise with the Treatment Information and Access Director, Health Policy Advisor, with the Senior Manager of Relations with Patient Organisations, with the Training Manager to ensure the link with the Capacity Building programmes and with the EU Public Affairs Manager, in charge of the global activity of the EURORDIS volunteers. 1 Main missions of this position and main areas of responsibility are: To help coordinating the EURORDIS’ activities related to the development and access to medicines for people living with rare diseases in Europe – orphan medicinal products but also paediatrics, gene and cell therapies, etc. To manage the process of patient engagement in Research & Development and beyond, through the different types of procedures by identification, invitation, exchange, information, training, support and follow-up of the EURORDIS patient representatives. To help managing the work of the EURORDIS volunteers/advocates involved in TAG – Therapeutic Action Group. To manage documents/bibliography in relation with EURORDIS’ action in the field of therapeutic development and market access. To update the communication to EURORDIS members regarding documents prepared by the European Medicines Agency and/or the European Network of HTA Agencies (EUnetHTA) Key tasks: Download and filing of folders received from the EMA or other entity, in relation with the activities of EURORDIS in the Scientific Committees and Working Parties of the Agency, as well as in HTA initiatives, etc. Review of the EMA documents on orphan medicinal products for lay public in collaboration with the EMA staff, such as the COMP Public Summaries of Opinion at the time of designation. Organisation and support to patient representatives’ participation as experts in the different evaluation procedures of medicinal products (EMA activities, other type of patient engagement such as HTA bodies, EU projects): Identification of patient experts and support with administrative requirements (Declaration of Interest, Confidentiality Undertaking, travel and accommodation). Currently the main activity is related to the engagement of patient representatives in the Protocol Assistance procedures and in parallel Scientific Advice / HTA assessment, but this may evolve in the future with the engagement of patient representatives in Risk / Benefit Assessment, Health Technology Assessment, Payers value assessment and reimbursement. Communication to EURORDIS members or regulatory / HTA documents of interests (new orphan drug designations, new marketing authorisation applications, CHMP opinions on the marketing authorisations, renewals, withdrawals or suspension, PRAC and CHMP agendas and minutes, EMA monthly letter to stakeholders, European Public Assessment Summaries, Risk Management Plan Summaries, Safety warnings, Questions & Answers documents, Medicines requiring additional Monitoring (black symbol), Information on shortages…) which may include update of EURORDIS website, e-news, social media… Follow-up the engagement of patients by making the link with the online community platform RareConnect (https://www.rareconnect.org/fr) and by entering and managing records in the EURORDIS Contact database for all patient representatives. Organisation and support to the TAG (Therapeutic Action group) activities in close relation with the TDD. Organisation of the monthly conference calls including taking minutes and sending reports, help with organising annual face-to-face meeting with the EURORDIS Board including travel and accommodation, follow-up on participation of the TAG members to the Scientific Committees and Working Parties of the EMA and on reimbursement claim forms for each TAG members. 2 When needed, direct communication with EMA staff to follow-up on procedures, information, reimbursement issue, invitations status… Management of internal Call for Expression of Interest and preparation of the application to EC calls for Expression of Interest to involve patient representatives in the Scientific Committees and Working Parties of the EMA and other institutions. Contribute to the preparation and dissemination of the monthly EURORDIS Therapeutic reports. Any other tasks in the scope of the position Skills and capabilities Languages: Fluent English speaker. Working level in French. Another European language will be a plus. Education: Minimum 5 years education in science, biology, pharmacy, or medicine. Work experience: Experience in an international environment in the health sector. The candidate needs to demonstrate excellent communication and proactive skills. IT: Fully operational with Word, Excel, Power Point Qualities: o Ability to work with patient advocacy groups and to support the work of volunteers (patient parents, professionals) to empower them. Minimum required will be to demonstrate ability to work closely with a wide variety of persons, to be openminded, curious, to have proactive relationship, to show empathy and to build social relationship. o International and inter-cultural profile o Commitment is essential in this position: concerned or really stimulated by rare diseases or other chronic medical conditions. o Team worker and Autonomous: multi-tasker, able to work under pressure. Logistics: Available to travel (~ 10 to 20% of the time) to support meetings at the EMA, organise or attend EURORDIS meetings and trainings all over Europe. 3